Thomas Braxton King, President & CEO at Alexza Pharmaceuticals Inc. (ALXA), sold 45,000 shares at $2.41 ($100K) on 2009-12-16, disclosed to the SEC on 2009-12-21.
Scheduled sale ($100k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.41 | 14,246 | $34K | 34.2% |
| 2 | $2.20 | 7,893 | $17K | 17.3% |
| 3 | $2.13 | 22,861 | $49K | 48.5% |
| Total | $2.23 avg | 45,000 | $100K | 100% |
| Filing → |
| ALXA | SELL | 2012-08-29 | $41K | — | Filing → |
| ALXA | SELL | 2012-06-08 | $22K | — | Filing → |
| ALXA | SELL | 2009-12-18 | $100K | — | Filing → |